The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for babies ...

Israel will face further sanctions from the UK if it fails to agree a ceasefire in Gaza, David Lammy said. “We’ve announced a ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Following the FDA ODD, European designation underscores ICT01’s potential as a ...

Medicines derived from living cells — biologics — are some of the most expensive medicines in America. What keeps prices ...

Czech Deputy Health Minister Michaela Matoušková urges the EU to take stronger, proactive steps on pharmaceutical policy, digital health coordination, and equitable access to innovative medicines.

The Breakthrough Therapy Designation (BTD) was granted based on the highly compelling results from the Phase 2 EMBOLD trial in SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) The ...

The shares of this leading pharmaceutical company are in focus after receiving further approval for its injection to treat ...

Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...